AU1099000A - Novel compounds and compositions for treating hepatitis c infections - Google Patents
Novel compounds and compositions for treating hepatitis c infectionsInfo
- Publication number
- AU1099000A AU1099000A AU10990/00A AU1099000A AU1099000A AU 1099000 A AU1099000 A AU 1099000A AU 10990/00 A AU10990/00 A AU 10990/00A AU 1099000 A AU1099000 A AU 1099000A AU 1099000 A AU1099000 A AU 1099000A
- Authority
- AU
- Australia
- Prior art keywords
- infections
- compositions
- novel compounds
- treating hepatitis
- hepatitis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000005176 Hepatitis C Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 title 1
- 208000010710 hepatitis C virus infection Diseases 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/645—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
- C07F9/6503—Five-membered rings
- C07F9/6506—Five-membered rings having the nitrogen atoms in positions 1 and 3
- C07F9/65068—Five-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10308598P | 1998-10-05 | 1998-10-05 | |
| US60103085 | 1998-10-05 | ||
| PCT/US1999/022850 WO2000020400A1 (en) | 1998-10-05 | 1999-10-04 | Novel compounds and compositions for treating hepatitis c infections |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU1099000A true AU1099000A (en) | 2000-04-26 |
Family
ID=22293315
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU10990/00A Abandoned AU1099000A (en) | 1998-10-05 | 1999-10-04 | Novel compounds and compositions for treating hepatitis c infections |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU1099000A (en) |
| WO (1) | WO2000020400A1 (en) |
Families Citing this family (40)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4341949B2 (en) | 2000-09-01 | 2009-10-14 | ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド | Azaheterocyclic derivatives and their therapeutic use |
| JP4361727B2 (en) | 2000-09-11 | 2009-11-11 | ノバルティス バクシンズ アンド ダイアグノスティックス，インコーポレーテッド | Quinolinone derivatives as tyrosine kinase inhibitors |
| AU2002230763A1 (en) * | 2000-12-13 | 2008-01-03 | Bristol-Myers Squibb Pharma Company | Inhibitors of hepatitis c virus ns3 protease |
| US6653295B2 (en) | 2000-12-13 | 2003-11-25 | Bristol-Myers Squibb Company | Inhibitors of hepatitis C virus NS3 protease |
| US7026111B2 (en) * | 2001-10-15 | 2006-04-11 | Beckman Coulter, Inc. | Methods and reagents for improved cell-based assays |
| US7119072B2 (en) | 2002-01-30 | 2006-10-10 | Boehringer Ingelheim (Canada) Ltd. | Macrocyclic peptides active against the hepatitis C virus |
| US7091184B2 (en) | 2002-02-01 | 2006-08-15 | Boehringer Ingelheim International Gmbh | Hepatitis C inhibitor tri-peptides |
| US6642204B2 (en) | 2002-02-01 | 2003-11-04 | Boehringer Ingelheim International Gmbh | Hepatitis C inhibitor tri-peptides |
| CA2496164C (en) | 2002-08-23 | 2010-11-09 | Chiron Corporation | Benzimidazole quinolinones and uses thereof |
| US20050075279A1 (en) | 2002-10-25 | 2005-04-07 | Boehringer Ingelheim International Gmbh | Macrocyclic peptides active against the hepatitis C virus |
| CA2501932C (en) | 2002-11-13 | 2014-03-11 | Chiron Corporation | Use of benzimidazole quinolinones for treating cancer |
| FI118418B (en) | 2003-04-17 | 2007-11-15 | Ecocat Oy | Aluminum-rounded catalytic converter for cleaning of gas leaks |
| HRP20080014T3 (en) | 2003-05-21 | 2008-02-29 | Boehringer Ingelheim International Gmbh | Hepatitis c inhibitor compounds |
| RS20060197A (en) | 2003-09-22 | 2008-09-29 | Boehringer Ingelheim International Gmbh., | Macrocyclic peptides active against the hepatitis c virus |
| ATE495185T1 (en) | 2004-01-21 | 2011-01-15 | Boehringer Ingelheim Int | MACROCYCLIC PEPTIDES ACTIVE AGAINST HEPATITIS C VIRUS |
| PT1719773E (en) | 2004-02-24 | 2009-06-03 | Japan Tobacco Inc | Fused heterotetracyclic compounds and use tehreof as hcv polymerase inhibitor |
| US20070049593A1 (en) | 2004-02-24 | 2007-03-01 | Japan Tobacco Inc. | Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor |
| JP4914355B2 (en) | 2004-07-20 | 2012-04-11 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Hepatitis C inhibitor peptide analog |
| UY29016A1 (en) | 2004-07-20 | 2006-02-24 | Boehringer Ingelheim Int | ANALOGS OF INHIBITING DIPEPTIDES OF HEPATITIS C |
| BRPI0513811A (en) * | 2004-07-27 | 2008-07-15 | Gilead Sciences Inc | imidazo [4,5-d] pyrimidines, their uses and processes of preparation |
| US7659263B2 (en) | 2004-11-12 | 2010-02-09 | Japan Tobacco Inc. | Thienopyrrole compound and use thereof as HCV polymerase inhibitor |
| AU2006247062A1 (en) | 2005-05-17 | 2006-11-23 | Novartis Ag | Methods for synthesizing heterocyclic compounds |
| US8017612B2 (en) | 2006-04-18 | 2011-09-13 | Japan Tobacco Inc. | Piperazine compound and use thereof as a HCV polymerase inhibitor |
| EP1886685A1 (en) | 2006-08-11 | 2008-02-13 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods, uses and compositions for modulating replication of hcv through the farnesoid x receptor (fxr) activation or inhibition |
| US7906655B2 (en) * | 2008-08-07 | 2011-03-15 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| US9139569B2 (en) | 2009-05-12 | 2015-09-22 | Merck Sharp & Dohme Corp. | Fused tricyclic aryl compounds useful for the treatment of viral diseases |
| US8772505B2 (en) | 2009-05-29 | 2014-07-08 | Merck Sharp & Dohme Corp. | Antiviral compounds composed of three aligned aryl moieties to treat diseases such as hepatitis C |
| CA2763140A1 (en) | 2009-05-29 | 2010-12-02 | Schering Corporation | Antiviral compounds composed of three linked aryl moieties to treat diseases such as hepatitis c |
| AU2010324871A1 (en) * | 2009-11-25 | 2012-06-14 | Merck Sharp & Dohme Corp. | Fused tricyclic compounds and derivatives thereof useful for the treatment of viral diseases |
| CA2785488A1 (en) | 2009-12-22 | 2011-07-21 | Merck Sharp & Dohme Corp. | Fused tricyclic compounds and methods of use thereof for the treatment of viral diseases |
| EP2545060B1 (en) | 2010-03-09 | 2015-11-25 | Merck Sharp & Dohme Corp. | Fused tricyclic silyl compounds and methods of use thereof for the treatment of viral diseases |
| TWI515187B (en) | 2010-12-16 | 2016-01-01 | 健生科學愛爾蘭無限公司 | Anthraquinone as an antiviral agent for respiratory fusion virus |
| TWI541241B (en) * | 2010-12-16 | 2016-07-11 | 健生科學愛爾蘭無限公司 | Imidazopyridines as respiratory syncytial virus antiviral agents |
| TWI527814B (en) | 2010-12-16 | 2016-04-01 | 健生科學愛爾蘭無限公司 | Azabenzimidazoles as respiratory syncytial virus antiviral agents |
| TWI530495B (en) | 2010-12-16 | 2016-04-21 | 健生科學愛爾蘭無限公司 | Benzimidazole respiratory syncytial virus inhibitors |
| TWI501967B (en) * | 2010-12-16 | 2015-10-01 | Janssen R&D Ireland | Azaindoles as respiratory syncytial virus antiviral agents |
| WO2012107589A1 (en) | 2011-02-11 | 2012-08-16 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Methods and pharmaceutical compositions for the treatment and prevention of hcv infections |
| DE102011111991A1 (en) | 2011-08-30 | 2013-02-28 | Lead Discovery Center Gmbh | New cyclosporin derivatives |
| PL2864323T3 (en) | 2012-06-15 | 2017-09-29 | Janssen Sciences Ireland Uc | 1,3-dihydro-2h-benzimidazol-2-one derivatives substituted with heterocycles as respiratory syncytial virus antiviral agents |
| WO2021250180A1 (en) | 2020-06-11 | 2021-12-16 | Janssen Sciences Ireland Unlimited Company | Hemi (l)-tartrate forms of 3-({5-chloro-1-[3-(methylsulfonyl)propyl]-1h-indol-2 yl} methyl)-1-(2,2,2-trifluoroethyl)-1,3-dihydro-2h-imidazo[4,5-c]pyridin-2-one and pharmaceutical compositions comprising the same |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH406305A (en) * | 1960-09-30 | 1966-01-31 | Gretag Ag | Method and device for the simultaneous triggering of a switching process in at least two devices |
| US5693515A (en) * | 1995-04-28 | 1997-12-02 | Arris Pharmaceutical Corporation | Metal complexed serine protease inhibitors |
| PL336233A1 (en) * | 1997-04-07 | 2000-06-19 | Axys Pharm Inc | Compounds and agents for treating diseases associated with serinic protease activity, in particular tryptase activity |
-
1999
- 1999-10-04 AU AU10990/00A patent/AU1099000A/en not_active Abandoned
- 1999-10-04 WO PCT/US1999/022850 patent/WO2000020400A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000020400A1 (en) | 2000-04-13 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU4813197A (en) | Compositions and methods for treating viral infections | |
| EP1128832A4 (en) | Compounds, compositions and methods for treating or preventing viral infections and associated diseases | |
| EP1292603B8 (en) | Methods and compositions for treating hepatitis c virus | |
| AU2951299A (en) | Disinfecting compositions and processes for disinfecting surfaces | |
| AU1296099A (en) | Methods and compositions for treating dermatoses | |
| HRP970201B1 (en) | Compositions for treating fungal infections | |
| IL148803A0 (en) | Novel composition and method for stabilizing the same | |
| AU4392199A (en) | Medicinal compositions for treating evacuatory insufficiency | |
| AU3835399A (en) | Perfume composition | |
| AU5029700A (en) | Glycopeptide antibacterial compounds, compositions containing same and methods of using same | |
| AU7165498A (en) | Methods for treating viral infections | |
| AU3858600A (en) | Glucamine compounds for treating hepatitis virus infections | |
| AU1733300A (en) | Copolymer compositions for treating viral infections | |
| AU7961498A (en) | 9a-azalides, compositions containing such compounds and methods of treatment | |
| AU2021601A (en) | Composition for the treatment of dandruff | |
| AU7986098A (en) | 9a-aza-3-ketolides, compositions containing such compounds and methods of treatment | |
| GC0000101A (en) | Novel composition for the prophylaxis of hepatitis. | |
| AU5704800A (en) | Medicinal compositions for preventing or treating diarrhea | |
| AU4198899A (en) | Stabilized composition based on pyridinyl-sulfinyl-benzimidazoles and process | |
| AU2207001A (en) | Novel compounds and process | |
| AU5056199A (en) | Molluscicidal composition | |
| AU2350195A (en) | Surfactant composition | |
| AU2961699A (en) | Medicinal compositions for treating edema | |
| AU4165699A (en) | Composition for treating cartilage disease | |
| AU4993000A (en) | Waste treatment composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |